SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 81 filers reported holding SUTRO BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $201,000 | -69.5% | 19,694 | -67.2% | 0.03% | +55.6% |
| Q4 2019 | $660,000 | +59.0% | 60,008 | +31.4% | 0.02% | +80.0% |
| Q3 2019 | $415,000 | +50.4% | 45,660 | +88.5% | 0.01% | +66.7% |
| Q2 2019 | $276,000 | -39.5% | 24,223 | -39.5% | 0.01% | -40.0% |
| Q1 2019 | $456,000 | -8.2% | 40,013 | -27.3% | 0.01% | -23.1% |
| Q4 2018 | $497,000 | -58.6% | 55,068 | -31.0% | 0.01% | -48.0% |
| Q3 2018 | $1,201,000 | – | 79,856 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $27,359,172 | 1.46% |
| Samsara BioCapital, LLC | 1,675,579 | $7,791,442 | 1.37% |
| Kynam Capital Management, LP | 1,500,000 | $6,975,000 | 0.96% |
| Parkman Healthcare Partners LLC | 1,143,861 | $5,318,954 | 0.92% |
| Rubric Capital Management LP | 4,048,744 | $18,826,660 | 0.80% |
| BVF INC/IL | 3,347,946 | $15,567,949 | 0.43% |
| Opaleye Management Inc. | 307,000 | $1,427,550 | 0.34% |
| SECTORAL ASSET MANAGEMENT INC | 400,646 | $1,863,004 | 0.31% |
| DAFNA Capital Management LLC | 242,779 | $1,128,922 | 0.31% |
| Eversept Partners, LP | 747,912 | $3,477,791 | 0.29% |